Skip to main content
Premium Trial:

Request an Annual Quote

Industrial Genomics Firm, Sequenom, Files for IPO

Premium

SAN DIEGO--The industrial genomics and bioinformatics company Sequenom announced last week that it had filed with the Securities and Exchange Commission for a public offering of common stock. The offering was led by Warburg Dillon Read, with assistance from Robertson Stephens and SG Cowen. The underwriters will be granted a 30-day over-allotment option to purchase additional shares of common stock from the company.

Sequenom's MassArray system combines proprietary enzymology and bioinformatics in a miniaturized chip-based format with mass spectrometry.

Proceeds of the offering will be used to hire additional sales and support personnel, expand its facilities, continue to develop and manufacture existing products, research and develop additional products, and to prosecute patents. Funds could also be used to acquire products, technologies, or companies, and to repay long-term debt and accrued interest of approximately $4.2 million, the company said.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.